Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials
Date of this Version
4-1-2019
Document Type
Letter to the Editor
Recommended Citation
Garmendia, Craig A.; Nassar Gorra, Liliana; Rodriguez, Ana Lucia; Trepka, Mary Jo; Veledar, Emir; and Madhivanan, Purnima, "Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials" (2019). Department of Biostatistics Faculty Publications. 89.
https://digitalcommons.fiu.edu/biostatistics_fac/89